OptimizeRx Corp has recently updated its beneficial ownership information through a filing by Royce & Associates LP, indicating that the investment firm now holds approximately 6.98% of the company's common stock. This amendment to the Schedule 13G filing, dated October 21, 2026, underscores the growing interest from investment management firms in the business services sector.
Royce & Associates LP, based in New York, has reported beneficial ownership of 1,315,057 shares of OptimizeRx, which reflects their sole voting and dispositive power over these shares. This move is significant as it showcases the increasing involvement of investment firms in influencing the direction and governance of companies within the business services landscape.
Background
OptimizeRx Corp, incorporated in Nevada, operates within the business services sector, specifically categorized under the SIC code 7389, which covers services in business services, NEC (not elsewhere classified). The company trades on the Nasdaq under the ticker symbol OPRX. Recent filings indicate a consistent flow of activity, including a Schedule 13G/A on October 21, 2026, and several Form 4 filings in September and August.
What the Filing Says
The recent Schedule 13G/A filing reveals that Royce & Associates LP beneficially owns 1,315,057 shares of OptimizeRx, representing 6.98% of the total class of common stock. The filing states, "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities." This statement emphasizes the firm’s intent to manage its investment without seeking to influence company control.
Impact
This update may affect various stakeholders, including shareholders, management, and potential investors. The increased stake by Royce & Associates could signal confidence in OptimizeRx's business model and growth potential, which may encourage other investors to take a closer look at the company. Additionally, the filing highlights the role of investment management firms in shaping the strategic landscape of the business services sector.
What's Next
The filing does not say what happens next. However, the ongoing interest from Royce & Associates may lead to further developments regarding OptimizeRx's strategic initiatives or future filings as the firm continues to manage its investment.